首页> 外文期刊>Medicine. >Salviae miltiorrhizae and ligustrazine hydrochloride injection combined with mecobalamin for treating diabetic peripheral neuropathy
【24h】

Salviae miltiorrhizae and ligustrazine hydrochloride injection combined with mecobalamin for treating diabetic peripheral neuropathy

机译:Salviae Miltiorrhizae和Ligustazine盐酸盐注射液相同,与Mecobalamin治疗糖尿病外周神经病变

获取原文
           

摘要

OBJECTIVE:Currently, it is unclear whether the salviae miltiorrhizae (Danshen Salvia) and ligustrazine hydrochloride (Chuanxiong Chuanxiong) (SMLH) injection combined with mecobalamin can improve diabetic peripheral neuropathy (DPN). We conducted a systematic analysis to evaluate the clinical effects of SMLH injection combined with mecobalamin for treating DPN.METHODS:Seven databases, including PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wan Fang Database (Wang Fang), Chinese Biomedical Literature Database (CBM), and VIP Database for Chinese Technical Periodicals (VIP) were searched for systematic literature retrieval. Each database was searched up to 2020 to identify randomized controlled trials on DPN treated with SMLH injection combined with mecobalamin. We used the RevMan 5.3 and Stata 14.0 software to assess the risk of bias in the included trials.RESULTS:A total of 15 publications, including 1349 samples, were reviewed. The total effective rate of SMLH injection combined with mecobalamin was 31% higher than that of mecobalamin alone (95% confidence interval [CI] = 1.23-1.38; P??.00001). The experimental group showed a significant increase in the motor conduction velocity (MCV) of the peroneal nerve (weighted mean difference [WMD] = 4.81, 95% CI 3.53-6.09; P??.00001). In addition, SMLH injection combined with mecobalamin showed a statistical significant effect on the sensory conduction velocity (SCV) of the peroneal nerve (WMD = 5.03, 95% CI?=?4.16-5.90; P??.00001), and MCV of the median nerve (WMD?=?5.38, 95% CI?=?4.05-6.72; P??.00001). The WMD for the change in SCV in the median nerve was 4.89?m/s (95% CI?=?3.88-5.89; P??.00001). The P-values of the Egger and Begg tests were 0.967 and 0.961, respectively, indicating no publication bias. Subgroup and sensitivity analyses indicated that the results for MCV and SCV of the peroneal nerve and the median nerve were stable.CONCLUSION:SMLH injection combined with mecobalamin can improve DPN, compared with mecobalamin alone.Copyright ? 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
机译:目的:目前,目前还不清楚丹参(Danshen Salvia)和盐酸虾菌(川芎川芎)(川芎)(SMLH)注射与Mecobalamin联合可以改善糖尿病外周神经病变(DPN)。我们进行了系统分析,以评估SMLH注射液与Mecobalamin治疗DPN的临床疗效。方法:七个数据库,包括PubMed,Embase,Cochrane图书馆,中国国家知识基础设施(CNKI),万芳数据库(王芳),中国人搜集了中国技术期刊(VIP)的生物医学文献数据库(CBM)和VIP数据库,用于系统文献检索。每个数据库都被搜索到2020年,以确定用SMLH注射治疗的DPN上的随机对照试验与Mecobalamin合并。我们使用Revman 5.3和Stata 14.0软件来评估包括的试验中的偏见风险。结果:综述了总共15个出版物,其中包括1349个样本。单独的Mecobalamin的SMLH注射的总有效速率比单独的mecobalamin(95%置信区间[CI] = 1.23-1.38;p≤00001)高出31%。实验组显示出腓神经的电动机传导速度(MCV)显着增加(加权平均差[WMD] = 4.81,95%CI 3.53-6.09;p≤00001)。此外,SMLH注射与Mecobalamin联合的统计显着影响对心肺神经的感觉传导速度(SCV)(WMD = 5.03,95%CI =Δ= 4.16-5.90;p≤00001),和中位神经的MCV(WMD?=?5.38,95%CI?=?4.05-6.72; p?& 00001)。在中位神经中SCV的变化的WMD为4.89?M / s(95%CI?= 3.88-5.89; p?& 00001)。 Egger和Begg测试的P值分别为0.967和0.961,表明没有出版物偏差。亚组和敏感性分析表明,心肺神经和中位神经的MCV和SCV的结果是稳定的。结论:与单独的Mecobalamin相比,SMLH注射结合Mecobalamin。 2021提交人。由Wolters Kluwer Health,Inc。出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号